Procarbazine Therapy for Hodgkin's Disease in Early Pregnancy
- 23 September 1968
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 205 (13) , 935-937
- https://doi.org/10.1001/jama.1968.03140390059020
Abstract
Procarbazine hydrochloride, an antineoplastic agent, a teratogen, and a carcinogen, was given to a patient with Hodgkin's disease during the first 5 1/2 weeks of her pregnancy, and a normal infant was delivered. Based on past experience with chemotherapeutic agents given to pregnant women with Hodgkin's disease, the authors present a program of management for the pregnant patient with Hodgkin's disease.Keywords
This publication has 0 references indexed in Scilit: